Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Blood-brain Barrier

The Blood-brain Barrier

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Piper rhythm-like electromyographical activity in muscle stiffness in sodium channel myotonia representing potassium-aggravated myotonia and myotonia permanens.

Journal of neurophysiology·2025

Same author

The Use of Vessel Wall Imaging for Making an Early Diagnosis of Giant Cell Arteritis in a Case with Cerebral Infarction.

Internal medicine (Tokyo, Japan)·2025

Same author

A Diagnostic Approach to VZV Vasculopathy Using MR Vessel Wall Imaging.

Internal medicine (Tokyo, Japan)·2025

Same author

Impact of istradefylline on motor and non-motor symptoms in patients with Parkinson's disease: Subanalysis of the ISTRA ADJUST PD.

Clinical parkinsonism & related disorders·2025

Same author

Impact of Istradefylline on Levodopa Dose Escalation in Parkinson's Disease: ISTRA ADJUST PD Study, a Multicenter, Open-Label, Randomized, Parallel-Group Controlled Study.

Neurology and therapy·2024

Same author

Nationwide Laboratory Surveillance of Progressive Multifocal Leukoencephalopathy in Japan: Fiscal Years 2011-2020.

Viruses·2023

Search research articles

Related Experiment Video

Updated: Feb 22, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

Immunoadsorption in neurological disorders.

Satoru Oji¹, Kyoichi Nomura¹

¹Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan.

Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis

|September 19, 2017

Summary

This summary is machine-generated.

Immunoadsorption selectively removes harmful factors from blood for autoimmune neurological disorders. While promising, more clinical evidence is needed to confirm its effectiveness compared to plasma exchange.

Keywords:

Autoantibody Immunoadsorption Indication category Neurological disorder Therapeutic plasma exchange

More Related Videos

Simultaneous Flow Cytometric Characterization of Multiple Cell Types Retrieved from Mouse Brain/Spinal Cord Through Different Homogenization Methods

Simultaneous Flow Cytometric Characterization of Multiple Cell Types Retrieved from Mouse Brain/Spinal Cord Through Different Homogenization Methods

Published on: November 19, 2019

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Published on: March 26, 2019

Related Experiment Videos

Last Updated: Feb 22, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

Simultaneous Flow Cytometric Characterization of Multiple Cell Types Retrieved from Mouse Brain/Spinal Cord Through Different Homogenization Methods

Simultaneous Flow Cytometric Characterization of Multiple Cell Types Retrieved from Mouse Brain/Spinal Cord Through Different Homogenization Methods

Published on: November 19, 2019

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Published on: March 26, 2019

Area of Science:

Neurology
Immunology
Blood Purification

Background:

Immunoadsorption is an emerging alternative to therapeutic plasma exchange for neurological disorders.
It selectively removes pathogenic humoral factors like autoantibodies and cytokines.
Current guidelines often favor therapeutic plasma exchange despite immunoadsorption's potential.

Purpose of the Study:

To review the clinical aspects and efficacy of immunoadsorption in treating neurological disorders.
To summarize existing evidence on immunoadsorption for autoimmune neurological conditions.
To highlight the need for further research to confirm its clinical utility.

Main Methods:

Review of clinical studies and guidelines on immunoadsorption for neurological disorders.
Analysis of immunoadsorption's mechanism of action, focusing on selective removal of humoral factors.
Comparison with therapeutic plasma exchange regarding fluid replacement and selectivity.

Main Results:

Immunoadsorption offers selective removal of pathogenic factors without requiring fluid replacement.
It has been studied for conditions including Guillain-Barré syndrome, myasthenia gravis, and multiple sclerosis.
Evidence suggests potential benefits, but it is not yet the primary recommended modality in most guidelines.

Conclusions:

Immunoadsorption is a viable blood purification technique for autoimmune neurological disorders.
Further clinical evidence is required to establish its efficacy and widespread adoption.
It holds promise for improving patient outcomes in autoimmune neurological diseases.